Atypical presentation of pulmonary aspergilloma in an immunocompetent individual: a case study and clinical conundrum
Abstract
Pulmonary aspergilloma typically develops in pre-existing lung cavities, while hemoptysis is the most recognized complication, spontaneous pneumothorax in immunocompetent patients is exceptionally rare.
We report a case of a 58-year-old immunocompetent male who presented with acute respiratory distress due to spontaneous pneumothorax. Chest imaging revealed an aspergilloma with cavity rupture into the pleural space. Despite chest tube drainage, persistent pneumothorax necessitated surgical intervention. The patient underwent conservative thoracotomy and received six months of voriconazole therapy, achieving complete recovery.
This case highlights an unusual presentation of pulmonary aspergilloma, emphasizing the importance of considering fungal etiology in post-tuberculosis patients presenting with pneumothorax.
References
- Fosses Vuong M, Hollingshead CM, Waymack JR. Aspergillosis. In: StatPearls. 2023. Available from: https://www.ncbi.nlm.nih.gov/books/NBK482241/
- Briones-Claudett KH, Briones-Claudett MH, Posligua Moreno A, et al. Spontaneous pneumothorax after rupture of the cavity as the initial presentation of tuberculosis in the emergency department. Am J Case Rep. 2020;21:e920393-6. DOI: https://doi.org/10.12659/AJCR.920393
- Denning DW, Pleuvry A, Cole DC. Global burden of chronic pulmonary aspergillosis as a sequel to pulmonary tuberculosis. Bull World Health Organ. 2011;89:864-72. DOI: https://doi.org/10.2471/BLT.11.089441
- Gupta PP, Fotedar S, Agarwal D, et al. Pneumothorax: a rare presentation of pulmonary mycetoma. Ann Thorac Med. 2007;2:171-2. DOI: https://doi.org/10.4103/1817-1737.36554
- Cai L, Gao P, Wang Z, et al. Lung and gut microbiomes in pulmonary aspergillosis: exploring adjunctive therapies to combat the disease. Front Immunol. 2022;13:988708. DOI: https://doi.org/10.3389/fimmu.2022.988708
- Cadena J, Thompson GR 3rd, Patterson TF. Aspergillosis: epidemiology, diagnosis, and treatment. Infect Dis Clin North Am. 2021;35:415-34. DOI: https://doi.org/10.1016/j.idc.2021.03.008
- Denning DW, Cadranel J, Beigelman-Aubry C, et al. Pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management. Eur Respir J. 2016;47:45-68.
- Latgé J-P, Chamilos G. Aspergillus fumigatus and Aspergillosis in 2019. Clin Microbiol Rev. 2019;33:e00140-218. DOI: https://doi.org/10.1128/CMR.00140-18
- Ben-Ami R, Lewis RE, Leventakos K, Kontoyiannis DP. Aspergillus fumigatus inhibits angiogenesis through the production of gliotoxin and other secondary metabolites. Blood. 2009;114:5393-9. DOI: https://doi.org/10.1182/blood-2009-07-231209
- Vukicevic TA, Dudvarski-Ilic A, Zugic V, et al. Subacute invasive pulmonary aspergillosis as a rare cause of pneumothorax in immunocompetent patient: brief report. Infection. 2017;45:377-80. DOI: https://doi.org/10.1007/s15010-017-0994-3
- Khan R, Malik NI, Razaque A. Imaging of pulmonary post-tuberculosis sequelae. Pak J Med Sci. 2020;36:S75-82. DOI: https://doi.org/10.12669/pjms.36.ICON-Suppl.1722
- Denning DW, Cadranel J, Beigelman-Aubry C, et al. Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management. Eur Respir J. 2016;47:45-68. DOI: https://doi.org/10.1183/13993003.00583-2015
- Denning DW, Park S, Lass-Florl C, et al. High-frequency triazole resistance found in nonculturable Aspergillus fumigatus from lungs of patients with chronic fungal disease. Clin Infect Dis. 2011;52:1123-9. DOI: https://doi.org/10.1093/cid/cir179
- Patterson TF, Thompson GR 3rd, Denning DW, et al. Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;63:e1-60. DOI: https://doi.org/10.1093/cid/ciw326
- Sakuraba M, Sakao Y, Yamasaki A, et al. A case of aspergilloma detected after surgery for pneumothorax. Annals of Thoracic and Cardiovascular Surgery. 2006;12:267-9.
Metrics
Citations and online attention from Dimensions, Altmetric and PlumX.
License
Copyright (c) 2025 the Author(s)

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.